Name

Afa­tinib

Syn­onyms

Afa­tinib;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;4-[(3-chloro-4-fluorophenyl)aMino]-6-{[4-(N,N-diMethylaMino)-1-oxo-2-buten-1-yl]aMino}-7-((S)-tetrahydrofuran-3-yloxy)-quinazoline;2-ButenaMide,N-[4-[(3-chloro-4-fluorophenyl)aMino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(diMethylaMino)-,(2E)-;(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dime;AfatinibAPI;Afatinib(BIBW2992MA2);Afatinib(with1int.)

Mol­e­c­u­lar Formula

C24H25ClFN5O3

Mol­e­c­u­lar Weight

485.9384032

CAS Num­ber (Or Wat­son Num­ber for Non-CAS Products)

850140-72-6

EINECS

Appear­ance

Specs/​Standards

Enter­prise Stan­dard

Use

Links

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd (http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing link http://​cam​ing​.com/​A​f​a​t​i​n​i​b​-​c​a​s​-​8​5​0​1​4​0​-​7​2​-6/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly. 

























    Please prove you are human by select­ing the plane.




    Dis­claimer

    This prod­uct is for research and devel­op­ment pur­pose only which may not be used direct­ly as drugs, food, cos­met­ics or for any oth­er non-R&D pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.